Webinar AI and drug development
Advancing Drug Development and Outcomes Research with Artificial Intelligence,
Machine Learning, and Predictive Models
Richard Gliklich, MD
Founder and CEO, OM1
Wed, July 18, 2018, 1:00 pm to 2:00 pm EDT
Register for free at https://www.rosaandco.com/webinars
Abstract: The convergence of AI, machine learning, predictive modeling and big
data enable the ability to measure, predict and personalize care in a way
previously not possible.
Join Dr. Richard Gliklich, CEO of OM1, as he explores the applications of AI
tools and models to accelerate research, measure and benchmark outcomes, and
demonstrate value.